LON/0HTG (LON/0HTG)

London Stock Exchange: LON/0HTG · USD

$245

-2.15 (-0.9%)· Recorded snapshot

Market cap	42.6B
Revenue (ttm)	191.6B
Net income (ttm)	1.3B
EPS (ttm)	$5.44
P/E (trailing)	33.9x
P/E (forward)	19.5x
Dividend	$1.55 (0.84%)
Volume	424
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 191.6B
Net income (ttm): 1.3B
EPS (ttm): $5.44
P/E (trailing): 33.9x
P/E (forward): 19.5x
Market cap: 42.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.5

P25 n/aP50 n/aP75 n/a

Trailing P/E33.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC18.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0HTG indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-11-05
Employees	63,900
Employees change	6,200
Employees growth	10.75%
Enterprise value	$46.6B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1979
Industry	Medical Distribution
Is primary listing	No
ISIN number	US14149Y1082
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Market cap	$42.6B
Next earnings date	2026-11-05
Price	$245.34
Price currency	USD
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-28
Symbol	lon/0HTG
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	181.56x
Average P/E ratio (3Y)	34.74x
Average P/E ratio (5Y)	35.65x
Earnings yield	2.95%
EV/Earnings	36.28x
EV/EBIT	18.97x
EV/EBITDA	13.74x
EV/FCF	13.74x
EV/Sales	0.25x
FCF / EV yield	7.28%
FCF yield	7.95%
Forward P/E	19.5x
Lynch fair value	$170.47
Lynch upside	-30.98%
P/(FCF - SBC) ratio	13.68x
P/(OCF - SBC) ratio	11.84x
P/E ratio	33.93x
P/FCF ratio	12.57x
P/OCF ratio	11x
P/S ratio	0.22x
Price/EBITDA ratio	13.41x
Sector forward P/E	14.52x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.29%
EBITDA margin	1.67%
Effective tax rate	21.57%
FCF margin	1.78%
Gross margin	3.84%
Operating margin	1.29%
Pretax margin	0.86%
Profit margin	0.67%
Profit per employee	$21,059
Profitable quarters	12
Profitable years	4
Revenue per employee	$3.1M
ROA	3.72%
ROA (5Y)	2.96%
ROCE	24.55%
ROIC	18.36%
ROIC (5Y)	15.17%
SBC / revenue	0.14%
Tax / revenue	0.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.09%
EPS growth (Q)	68.8%
EPS growth (QoQ)	-0.54%
EPS growth 10Y	5.28%
EPS growth 3Y	79.03%
EPS growth 5Y	28.3%
EPS growth quarters	1
EPS growth years	4
FCF growth	144.6%
FCF growth (Q)	10.87%
FCF growth (QoQ)	-14.85%
FCF growth 3Y	24.18%
FCF growth 5Y	17.4%
Gross profit growth	19.66%
Gross profit growth (Q)	16.26%
Gross profit growth 3Y	12.45%
Gross profit growth 5Y	7.6%
Net income growth	9.8%
Net income growth (Q)	66.53%
Net income growth (QoQ)	-0.25%
Net income growth 3Y	73.18%
Net income growth 5Y	22.91%
Net income growth quarters	1
Net income growth years	4
OCF growth	115.85%
OCF growth (Q)	11.32%
OCF growth (QoQ)	-7.19%
OCF growth 10Y	5.7%
OCF growth 3Y	22.08%
OCF growth 5Y	16.33%
Operating income growth	32.26%
Operating income growth (Q)	34.02%
Operating income growth 3Y	22.49%
Operating income growth 5Y	12.88%
Revenue growth	14.23%
Revenue growth (Q)	5.84%
Revenue growth (QoQ)	4.48%
Revenue growth 10Y	7.66%
Revenue growth 3Y	7.44%
Revenue growth 5Y	9.37%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-489.2M
Depreciation and amortization	$719.6M
EBIT	$2.5B
EBITDA	$3.2B
EPS	$5.44
Financing cash flow	$-1.2B
Free cash flow	$3.4B
Free cash flow minus SBC	$3.1B
Gross profit	$7.4B
Income taxes	$353.5M
Investing cash flow	$-1.9B
Net borrowing	$253.7M
Net cash flow	$740.1M
Net income	$1.3B
Operating cash flow minus SBC	$3.6B
Operating income	$2.5B
Revenue	$191.6B
Stock-based compensation	$276.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.02
Book value per share	$-9.33
Debt / EBITDA	2.2
Debt / FCF	2.21
Goodwill	$8.6B
Interest coverage	9.45
Long-term assets	$14B
Long-term liabilities	$12.2B
Net cash (debt)	$-3.9B
Net cash / market cap	-9.04%
Net debt / EBITDA	1.21
Net debt / FCF	1.14
Piotroski F-Score	7
Property, plant and equipment	$3B
Shareholders' equity	$-2.1B
Tangible book value	$-12.4B
Tangible book value per share	$-53.42
Total assets	$43.2B
Total cash	$3.7B
Total debt	$7.5B
Total liabilities	$45.2B
WACC	6.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.61
Current assets	$29.2B
Current liabilities	$33B
Current ratio	0.88
Inventory turnover	14.33
Net working capital	$-6B
Quick ratio	0.43
Working capital	$-3.9B
Working capital turnover	-49.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.07%
Dividend growth	1%
Dividend growth (3Y)	1%
Dividend growth (5Y)	1%
Dividend growth years	1
Dividend payment date	2026-10-15
Dividend payment years	10
Dividend payout frequency	Quarterly
Dividend per share	$1.55
Dividend yield	0.84%
Ex-dividend date	2026-10-01
Last dividend	$0.52
Payout ratio	28.65%
Shareholder yield	2.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$223.22
1D price change	-0.87%
1M price change	11.91%
1M total return	12.17%
1W price change	-3.31%
1W total return	-3.31%
1Y price change	50.81%
1Y return CAGR	52.28%
1Y total return	52.23%
20-day SMA	$243.52
200-day SMA	$221.75
3M price change	7.36%
3M total return	7.61%
3Y price change	170.38%
3Y return CAGR	41.3%
3Y total return	182.2%
50-day SMA	$236.89
50-day SMA vs 200-day SMA	50over200
52-week high	$264.00
52-week high date	2026-10-22
52-week low	$161.85
52-week low date	2025-10-29
5Y price change	416.68%
5Y return CAGR	41.74%
5Y total return	471.89%
6M price change	21.17%
6M total return	21.71%
All-time high	$264.00
All-time high date	2026-10-22
All-time low	$41.92
All-time low date	2019-08-07
Average true range (ATR)	$9.28
Average volume	955.5
Beta (5Y)	0.5
Change from 52-week high	-7.07%
Change from 52-week low	51.59%
Change from all-time high	-6.79%
Change from all-time low	487%
Change from open	0.83%
Day's gap	-1.69%
Dollar volume	$104,024
High price	$252.01
Low price	$243.31
Monthly RSI	69.59
Open price	$243.31
Position in 52-week range	23.33%
Previous close	$247.50
Price vs 150-day SMA	10.24%
Price vs 20-day SMA	1.05%
Price vs 200-day SMA	10.97%
Price vs 50-day SMA	3.88%
Relative volume	0.44
RSI	54.64
Sharpe ratio	1.55
Sharpe ratio (3Y)	1.32
Sharpe ratio (5Y)	1.34
Sortino ratio	3.05
Sortino ratio (3Y)	2.33
Sortino ratio (5Y)	2.33
Volume	424
Weekly RSI	59.75
YTD price change	18.85%
YTD total return	19.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	231.1M
Shares change (QoQ)	-0.42%
Shares change (YoY)	-2.07%
Shares held by insiders	0.08%
Shares held by institutions	90.6%
Short ratio	4.2 days

Deeper analysis on LON/0HTG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0HTG report

Is a complete LON/0HTG research report available?

No complete published report is available for lon/0HTG (LON/0HTG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0HTG (LON/0HTG)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0HTG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0HTG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0HTG

Frequently asked questions